Network-based prioritization and validation of regulators of vascular smooth muscle cell proliferation in disease

• Published in: Nature cardiovascular research Vol. 3; no. 6; p. 714
• Main Authors: Lambert, Jordi, Oc, Sebnem, Worssam, Matthew D, Häußler, Daniel, Solomon, Charles U, Figg, Nichola L, Baxter, Ruby, Imaz, Maria, Taylor, James C K, Foote, Kirsty, Finigan, Alison, Mahbubani, Krishnaa T, Webb, Tom R, Ye, Shu, Bennett, Martin R, Krüger, Achim, Spivakov, Mikhail, Jørgensen, Helle F
• Format: Journal Article
• Language: English
• Published: England 01.01.2024
• Subjects: Epigenomics; Vascular diseases; Regulatory networks; Transcriptomics
• ISSN: 2731-0590
• DOI: 10.1038/s44161-024-00474-4

Aberrant vascular smooth muscle cell (VSMC) homeostasis and proliferation characterize vascular diseases causing heart attack and stroke. Here we elucidate molecular determinants governing VSMC proliferation by reconstructing gene regulatory networks from single-cell transcriptomics and epigenetic profiling. We detect widespread activation of enhancers at disease-relevant loci in proliferation-predisposed VSMCs. We compared gene regulatory network rewiring between injury-responsive and nonresponsive VSMCs, which suggested shared transcription factors but differing target loci between VSMC states. Through in silico perturbation analysis, we identified and prioritized previously unrecognized regulators of proliferation, including RUNX1 and TIMP1. Moreover, we showed that the pioneer transcription factor RUNX1 increased VSMC responsiveness and that TIMP1 feeds back to promote VSMC proliferation through CD74-mediated STAT3 signaling. Both RUNX1 and the TIMP1-CD74 axis were expressed in human VSMCs, showing low levels in normal arteries and increased expression in disease, suggesting clinical relevance and potential as vascular disease targets.